Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Poe, Jonathan C ^a   Smith, Susan H ^a   Haas, Karen M ^a   Yanaba, Koichi ^a   Tsubata, Takeshi ^b   Matsushita, Takashi ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD40 LIGAND; IMMUNOGLOBULIN G; INTERLEUKIN 10; CD22 ANTIGEN; CD40 ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SPLEEN CELL; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL COUNT; CYTOLOGY; IMMUNOLOGY; METABOLISM; PHENOTYPE;

MUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, CD22; ANTIGENS, CD40; AUTOANTIBODIES; B-LYMPHOCYTES, REGULATORY; CD40 LIGAND; CELL COUNT; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 79960728714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022464     Document Type: Article

References (54)

1. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, et al. (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990-993.
2. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, et al. (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291-300.
3. Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, et al. (1994) CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 91: 12135-12139.
4. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, et al. (1994) The immune responses in the CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1: 167-178.
5. Tsubata T, Wu J, Honjo T, (1993) B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 12: 645-648.
6. Xu J, Foy TM, Laman JD, Elliott EA, Dunn JJ, et al. (1994) Mice deficient for the CD40 ligand. Immunity 1: 423.
7. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ, (1996) Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14: 591-617.
8. Dullforce P, Sutton DC, Heath AW, (1998) Enhancement of T cell-independent immune responses in vivo by CD40 antibodies. Nat Med 4: 88-91.
9. Erickson LD, Vogel LA, Cascalho M, Wong J, Wabl M, et al. (2000) B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system. Eur J Immunol 30: 3121-3131.
10. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ, (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
11. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, et al. (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
12. French RR, Chan HT, Tutt AL, Glennie MJ, (1999) CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help. Nat Med 5: 548-553.
13. Erickson LD, Durell BG, Vogel LA, O'Connor BP, Cascalho M, et al. (2002) Short-circuiting long-lived humoral immunity by the heightened engagement of CD40. J Clin Invest 109: 613-620.
14. Kishi Y, Aiba Y, Higuchi T, Furukawa K, Tokuhisa T, et al. (2010) Augmented Ab response with premature germinal center regression in CD40L transgenic mice. J Immunol 185: 211-219.
15. Bolduc A, Long E, Stapler D, Cascalho M, Tsubata T, et al. (2010) Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas. J Immunol 185: 220-230.
16. Blossom S, Chu EB, Weigle WO, Gilbert KM, (1997) CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol 159: 4580-4586.
17. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK, (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97: 2063-2073.
18. Grammer AC, Slota R, Fischer R, Gur H, Girschick H, et al. (2003) Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J Clin Invest 112: 1506-1520.
19. Kawamura T, Kanai T, Dohi T, Uraushihara K, Totsuka T, et al. (2004) Ectopic CD40 ligand expression on B cells triggers intestinal inflammation. J Immunol 172: 6388-6397.
20. Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, et al. (2002) Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 168: 9-12.
21. Doody GM, Justement LB, Delibrias CC, Mathews RJ, Lin J, et al. (1995) A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269: 242-244.
22. O'Keefe TL, Williams GT, Davies SL, Neuberger MS, (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274: 798-801.
23. Poe JC, Fujimoto M, Jansen PJ, Miller AS, Tedder TF, (2000) CD22 forms a quaternary complex with SHIP, Grb2 and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J Biol Chem 275: 17420-17427.
24. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, et al. (1996) CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5: 551-562.
25. Poe JC, Haas KM, Uchida J, Lee Y, Fujimoto M, et al. (2004) Severely-impaired B lymphocyte proliferation, survival and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J Immunol 172: 2100-2110.
26. DiLillo DJ, Matsushita T, Tedder TF, (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183: 38-57.
27. Yanaba K, Bouaziz J-D, Matsushita T, Tsubata T, Tedder TF, (2009) The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 182: 7459-7472.
28. Iwata Y, Matsushita T, Horikawa M, DiLillo DJ, Yanaba K, et al. (2011) Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541.
29. Fang W, Mueller DL, Pennell CA, Rivard JJ, Li YS, et al. (1996) Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 4: 291-299.
30. Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF, (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118: 3420-3430.
31. Matsushita T, Horikawa M, Iwata Y, Tedder TF, (2010) Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling EAE initiation and late-phase immunopathogenesis. J Immunol 185: 2240-2252.
32. Engel P, Zhou L-J, Ord DC, Sato S, Koller B, et al. (1995) Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3: 39-50.
33. DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, et al. (2008) Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 180: 361-371.
34. Haas KM, Sen S, Sanford IG, Miller AS, Poe JC, et al. (2006) CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J Immunol 177: 3063-3073.
35. Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, et al. (2004) CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol 5: 1078-1087.
36. Bouaziz J-D, Yanaba K, Tedder TF, (2008) Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 224: 201-214.
37. Yanaba K, Bouaziz J-D, Haas KM, Poe JC, Fujimoto M, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
38. Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, et al. (2010) Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 184: 4789-4800.
39. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr, (1996) Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184: 2271-2278.
40. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM, (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950.
41. Fillatreau S, Gray D, Anderton SM, (2008) Not always the bad guys: B cells as regulators of autoimmune pathology. Nature Rev Immunol 8: 391-397.
42. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK, (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
43. Serra P, Santamaria P, (2006) To 'B' regulated: B cells as members of the regulatory workforce. Trends Immunol 27: 7-10.
44. Mauri C, Ehrenstein MR, (2008) The 'short' history of regulatory B cells. Trends Immunol 29: 34-40.
45. Lund FE, (2008) Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 20: 332-338.
46. Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, et al. (2010) Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 184: 4801-4809.
47. Duddy ME, Alter A, Bar-Or A, (2004) Distinct profiles of human B cell effector cytokines: a role in immune regulation. J Immunol 172: 3422-3427.
48. Mauri C, Gray D, Mushtaq N, Londei M, (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197: 489-501.
49. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK, (1997) Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med 186: 1749-1756.
50. Smith SH, Haas KM, Poe JC, Yanaba K, Ward CD, et al. (2010) B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol 22: 681-691.
51. Stout RD, Suttles J, (1996) The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17: 487-492.
52. Wagner DH Jr, (2009) The co-evolution of our understanding of CD40 and inflammation. Diabetologia 52: 997-999.
53. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, et al. (2010) CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32: 129-140.
54. O'Keefe TL, Williams GT, Batista FD, Neuberger MS, (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189: 1307-1313.